CA 209017
Laufzeit: 01.01.2012 - 31.12.2014
imported
Kurzfassung
An open-label, randomized phase III trial of BMS-936558 versus Docetaxel in previously treated metastatic non-small-cell lung cancer (NSCLC)
Laufzeit: 01.01.2012 - 31.12.2014
An open-label, randomized phase III trial of BMS-936558 versus Docetaxel in previously treated metastatic non-small-cell lung cancer (NSCLC)